Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Sclerosis and IFNAR1[original query] |
---|
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis. Genes and immunity 2003 Mar 4 (2): 147-52. Sriram U, Barcellos L F, Villoslada P, Rio J, Baranzini S E, Caillier S, Stillman A, Hauser S L, Montalban X, Oksenberg J |
IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response. Journal of neuroimmunology 2005 Jun 163 (1-2): 165-71. Leyva Laura, Fernández Oscar, Fedetz Maria, Blanco Eva, Fernández Victoria E, Oliver Begoña, León Antonio, Pinto-Medel Maria-Jesus, Mayorga Cristobalina, Guerrero Miguel, Luque Gloria, Alcina Antonio, Matesanz Fuencis |
Pharmacogenomics of responsiveness to interferon IFN-beta treatment in multiple sclerosis: a genetic screen of 100 type I interferon-inducible genes. Clinical pharmacology and therapeutics 2005 Dec 78 (6): 635-46. Cunningham Stephen, Graham Colin, Hutchinson Michael, Droogan Aidan, O'Rourke Killian, Patterson Chris, McDonnell Gavin, Hawkins Stanley, Vandenbroeck Ko |
Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2006 Nov 60 (9): 569-77. Diop G, Hirtzig T, Do H, Coulonges C, Vasilescu A, Labib T, Spadoni J-L, Therwath A, Lathrop M, Matsuda F, Zagury J |
[Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]. Molekuliarnaia biologiia 0 45 (6): 963-72. Tsareva E Iu, Kulakova O G, Makarycheva O Iu, Bo?ko A N, Shchur S G, Lashch N Iu, Popova N F, Gusev E I, Bashinskaia V V, L'vov D V, Favorov A V, Ochs M F, Favorova O |
Allelic combinations of immune-response genes as possible composite markers of IFN-ß efficacy in multiple sclerosis patients. Pharmacogenomics 2012 Nov 13 (15): 1689-700. Kulakova Olga G, Tsareva Ekaterina Yu, Boyko Alexey N, Shchur Sergey G, Gusev Evgeny I, Lvovs Dmitrijs, Favorov Alexander V, Vandenbroeck Koen, Favorova Olga |
Comparative pharmacogenetics of multiple sclerosis: IFN-ß versus glatiramer acetate. Pharmacogenomics 2014 Apr 15 (5): 679-85. Kulakova Olga G, Tsareva Ekaterina Yu, Lvovs Dmitrijs, Favorov Alexander V, Boyko Alexey N, Favorova Olga |
Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF-ß therapy. IUBMB life 2016 Jun . Karam Rehab A, Rezk Noha A, Amer Mona M, Fathy Hala |
Association study of promoter polymorphisms of interferon alpha and beta receptor subunit 1 (IFNAR1) gene and therapeutic response to interferon-beta in patients with multiple sclerosis. Molecular biology reports 2021 Jul . Hajian Samin, Mazdeh Mehrdokht, Nouri Fatemeh, Roshanaei Ghodratollah, Soleimani Meys |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: